• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于动态集成选择的分类算法,用于预测HIV感染患者包膜蛋白的突变模式。

A classification algorithm based on dynamic ensemble selection to predict mutational patterns of the envelope protein in HIV-infected patients.

作者信息

Fili Mohammad, Hu Guiping, Han Changze, Kort Alexa, Trettin John, Haim Hillel

机构信息

Department of Industrial and Manufacturing Systems Engineering, Iowa State University, 3014 Black Engineering, 2529 Union Drive, Ames, IA, 50011, USA.

Department of Microbiology and Immunology, Carver College of Medicine, University of Iowa, 51 Newton Rd, 3-770 BSB, Iowa City, IA, 52242, USA.

出版信息

Algorithms Mol Biol. 2023 Jun 19;18(1):4. doi: 10.1186/s13015-023-00228-0.

DOI:10.1186/s13015-023-00228-0
PMID:37337202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10280944/
Abstract

BACKGROUND

Therapeutics against the envelope (Env) proteins of human immunodeficiency virus type 1 (HIV-1) effectively reduce viral loads in patients. However, due to mutations, new therapy-resistant Env variants frequently emerge. The sites of mutations on Env that appear in each patient are considered random and unpredictable. Here we developed an algorithm to estimate for each patient the mutational state of each position based on the mutational state of adjacent positions on the three-dimensional structure of the protein.

METHODS

We developed a dynamic ensemble selection algorithm designated k-best classifiers. It identifies the best classifiers within the neighborhood of a new observation and applies them to predict the variability state of each observation. To evaluate the algorithm, we applied amino acid sequences of Envs from 300 HIV-1-infected individuals (at least six sequences per patient). For each patient, amino acid variability values at all Env positions were mapped onto the three-dimensional structure of the protein. Then, the variability state of each position was estimated by the variability at adjacent positions of the protein.

RESULTS

The proposed algorithm showed higher performance than the base learner and a panel of classification algorithms. The mutational state of positions in the high-mannose patch and CD4-binding site of Env, which are targeted by multiple therapeutics, was predicted well. Importantly, the algorithm outperformed other classification techniques for predicting the variability state at multi-position footprints of therapeutics on Env.

CONCLUSIONS

The proposed algorithm applies a dynamic classifier-scoring approach that increases its performance relative to other classification methods. Better understanding of the spatiotemporal patterns of variability across Env may lead to new treatment strategies that are tailored to the unique mutational patterns of each patient. More generally, we propose the algorithm as a new high-performance dynamic ensemble selection technique.

摘要

背景

针对人类免疫缺陷病毒1型(HIV-1)包膜(Env)蛋白的疗法可有效降低患者体内的病毒载量。然而,由于突变,新的抗治疗Env变体频繁出现。每位患者Env上的突变位点被认为是随机且不可预测的。在此,我们开发了一种算法,可根据蛋白质三维结构上相邻位置的突变状态,为每位患者估计每个位置的突变状态。

方法

我们开发了一种名为k-best分类器的动态集成选择算法。它在新观察值的邻域内识别最佳分类器,并将其应用于预测每个观察值的变异状态。为评估该算法,我们应用了来自300名HIV-1感染个体的Env氨基酸序列(每位患者至少六个序列)。对于每位患者,将所有Env位置的氨基酸变异值映射到蛋白质的三维结构上。然后,通过蛋白质相邻位置的变异来估计每个位置的变异状态。

结果

所提出的算法表现出比基础学习器和一组分类算法更高的性能。Env的高甘露糖区域和CD4结合位点中多个治疗靶点位置的突变状态得到了很好的预测。重要的是,在预测治疗药物在Env上的多位点足迹处的变异状态方面,该算法优于其他分类技术。

结论

所提出的算法应用了一种动态分类器评分方法,相对于其他分类方法提高了其性能。更好地理解Env变异的时空模式可能会带来针对每位患者独特突变模式的新治疗策略。更一般地说,我们将该算法作为一种新的高性能动态集成选择技术提出。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6aa/10280944/df0ff27aca9c/13015_2023_228_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6aa/10280944/9f9d107d9997/13015_2023_228_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6aa/10280944/104f1cad7d1c/13015_2023_228_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6aa/10280944/0e59420b3fa1/13015_2023_228_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6aa/10280944/5394ff40afcc/13015_2023_228_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6aa/10280944/4f4b7dd70425/13015_2023_228_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6aa/10280944/68a0568e0e84/13015_2023_228_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6aa/10280944/df0ff27aca9c/13015_2023_228_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6aa/10280944/9f9d107d9997/13015_2023_228_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6aa/10280944/104f1cad7d1c/13015_2023_228_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6aa/10280944/0e59420b3fa1/13015_2023_228_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6aa/10280944/5394ff40afcc/13015_2023_228_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6aa/10280944/4f4b7dd70425/13015_2023_228_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6aa/10280944/68a0568e0e84/13015_2023_228_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6aa/10280944/df0ff27aca9c/13015_2023_228_Fig7_HTML.jpg

相似文献

1
A classification algorithm based on dynamic ensemble selection to predict mutational patterns of the envelope protein in HIV-infected patients.一种基于动态集成选择的分类算法,用于预测HIV感染患者包膜蛋白的突变模式。
Algorithms Mol Biol. 2023 Jun 19;18(1):4. doi: 10.1186/s13015-023-00228-0.
2
Conformational Engineering of HIV-1 Env Based on Mutational Tolerance in the CD4 and PG16 Bound States.基于 CD4 和 PG16 结合态突变容忍性的 HIV-1 包膜构象工程。
J Virol. 2019 May 15;93(11). doi: 10.1128/JVI.00219-19. Print 2019 Jun 1.
3
Key Positions of HIV-1 Env and Signatures of Vaccine Efficacy Show Gradual Reduction of Population Founder Effects at the Clade and Regional Levels.HIV-1 包膜的关键位置和疫苗功效特征表明,在进化枝和地区水平上,人群创始效应逐渐减少。
mBio. 2020 Jun 9;11(3):e00126-20. doi: 10.1128/mBio.00126-20.
4
Functional and Highly Cross-Linkable HIV-1 Envelope Glycoproteins Enriched in a Pretriggered Conformation.富含预触发构象的功能性和高度交联的 HIV-1 包膜糖蛋白。
J Virol. 2022 Apr 27;96(8):e0166821. doi: 10.1128/jvi.01668-21. Epub 2022 Mar 28.
5
Experimental Study and Comparison of Imbalance Ensemble Classifiers with Dynamic Selection Strategy.具有动态选择策略的不平衡集成分类器的实验研究与比较
Entropy (Basel). 2021 Jun 28;23(7):822. doi: 10.3390/e23070822.
6
Conformation of HIV-1 Envelope Governs Rhesus CD4 Usage and Simian-Human Immunodeficiency Virus Replication.HIV-1 包膜构象决定恒河猴 CD4 使用和猿猴-人免疫缺陷病毒复制。
mBio. 2022 Feb 22;13(1):e0275221. doi: 10.1128/mbio.02752-21. Epub 2022 Jan 11.
7
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.接受融合抑制剂(T-20)单药治疗的患者中出现1型耐药性人类免疫缺陷病毒。
Antimicrob Agents Chemother. 2002 Jun;46(6):1896-905. doi: 10.1128/AAC.46.6.1896-1905.2002.
8
Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers.未切割与成熟人免疫缺陷病毒膜包膜糖蛋白三聚体的比较。
J Virol. 2018 May 29;92(12). doi: 10.1128/JVI.00277-18. Print 2018 Jun 15.
9
HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.HIV-1 gp41 残基调节包膜糖蛋白中 CD4 诱导的构象变化和 gp120 构象的弛豫演化。
J Virol. 2018 Jul 31;92(16). doi: 10.1128/JVI.00583-18. Print 2018 Aug 15.
10
Induction of a Tier-1-Like Phenotype in Diverse Tier-2 Isolates by Agents That Guide HIV-1 Env to Perturbation-Sensitive, Nonnative States.通过引导HIV-1包膜糖蛋白进入扰动敏感的非天然状态的因子,在多种二级分离株中诱导出类似一级的表型。
J Virol. 2017 Jul 12;91(15). doi: 10.1128/JVI.00174-17. Print 2017 Aug 1.

引用本文的文献

1
Scalable and robust machine learning framework for HIV classification using clinical and laboratory data.使用临床和实验室数据进行HIV分类的可扩展且稳健的机器学习框架。
Sci Rep. 2025 May 28;15(1):18727. doi: 10.1038/s41598-025-00085-4.
2
Mapping the Evolutionary Space of SARS-CoV-2 Variants to Anticipate Emergence of Subvariants Resistant to COVID-19 Therapeutics.绘制 SARS-CoV-2 变体的进化空间图以预测对 COVID-19 治疗药物具有抗性的亚变体的出现。
PLoS Comput Biol. 2024 Jun 10;20(6):e1012215. doi: 10.1371/journal.pcbi.1012215. eCollection 2024 Jun.

本文引用的文献

1
Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody.预测广泛中和抗体介导的 HIV-1 体内逃逸动力学
Proc Natl Acad Sci U S A. 2021 Jul 27;118(30). doi: 10.1073/pnas.2104651118.
2
Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study.在治疗经验丰富的个体中,HIV-1 附着抑制剂前药福替司韦的安全性和疗效:3 期 BRIGHTE 研究的第 96 周结果。
Lancet HIV. 2020 Nov;7(11):e740-e751. doi: 10.1016/S2352-3018(20)30240-X.
3
Opening the HIV envelope: potential of CD4 mimics as multifunctional HIV entry inhibitors.
打开 HIV 信封:CD4 模拟物作为多功能 HIV 进入抑制剂的潜力。
Curr Opin HIV AIDS. 2020 Sep;15(5):300-308. doi: 10.1097/COH.0000000000000637.
4
Key Positions of HIV-1 Env and Signatures of Vaccine Efficacy Show Gradual Reduction of Population Founder Effects at the Clade and Regional Levels.HIV-1 包膜的关键位置和疫苗功效特征表明,在进化枝和地区水平上,人群创始效应逐渐减少。
mBio. 2020 Jun 9;11(3):e00126-20. doi: 10.1128/mBio.00126-20.
5
Understanding the mechanisms driving the spread of subtype C HIV-1.理解推动 C 型 HIV-1 传播的机制。
EBioMedicine. 2020 Mar;53:102682. doi: 10.1016/j.ebiom.2020.102682. Epub 2020 Feb 27.
6
The High Content of Fructose in Human Semen Competitively Inhibits Broad and Potent Antivirals That Target High-Mannose Glycans.精液中高浓度的果糖会竞争性抑制广谱且强效的靶向高甘露糖聚糖的抗病毒药物。
J Virol. 2020 Apr 16;94(9). doi: 10.1128/JVI.01749-19.
7
Griffithsin Retains Anti-HIV-1 Potency with Changes in gp120 Glycosylation and Complements Broadly Neutralizing Antibodies PGT121 and PGT126.格里菲辛在 gp120 糖基化改变时保持抗 HIV-1 效力,并与广泛中和抗体 PGT121 和 PGT126 互补。
Antimicrob Agents Chemother. 2019 Dec 20;64(1). doi: 10.1128/AAC.01084-19.
8
A New Family of Small-Molecule CD4-Mimetic Compounds Contacts Highly Conserved Aspartic Acid 368 of HIV-1 gp120 and Mediates Antibody-Dependent Cellular Cytotoxicity.一种新型小分子 CD4 模拟化合物家族与 HIV-1 gp120 上高度保守的天冬氨酸 368 结合,并介导抗体依赖性细胞细胞毒性。
J Virol. 2019 Nov 26;93(24). doi: 10.1128/JVI.01325-19. Print 2019 Dec 15.
9
Molecular Mechanism of HIV-1 Entry.HIV-1 进入的分子机制。
Trends Microbiol. 2019 Oct;27(10):878-891. doi: 10.1016/j.tim.2019.06.002. Epub 2019 Jun 28.
10
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design.HIV-1 中和抗体特征及其在表位靶向疫苗设计中的应用。
Cell Host Microbe. 2019 Jan 9;25(1):59-72.e8. doi: 10.1016/j.chom.2018.12.001.